Delivery Order HT001122D0030-HT001122F0101
Award Date
6/19/23
Potential Completion Date
6/19/23
Potential Value
$2.5K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Falls Church, VA 22042, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract, valued at $57,500.00, is for IDIQ contract management support activities related to the BIO-AMT-2301 program. This appears to be an unset-aside contract. Lovelace Biomedical Research Institute has extensive experience supporting...
This is a $385,704.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the characterization of spontaneous osteogenesis, or bone formation, after surgical segmental bone defect in a large animal model. The work will take place in...
This is a delivery order contract awarded by the Air Education and Training Command, a defense agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The contract, valued at $794,540.92, is for Department of Clinical Investigation research support services under the Navy Medicine R&D Support Omnibus III contract vehicle. LBERI, a non-profit organization, provides preclinical research services to support the...
This is a $1,034,939.96 fixed-price definitive contract awarded by the Defense Health Agency (DHA) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The contract is for an Animal Management System software license and support. There is no set-aside designation for this award. Lovelace Biomedical Research Institute has experience as a prime contractor on federal contracts and grants, providing services across the drug and product development lifecycle...
This federal contract award is for the LOVELACE ANIMAL MANAGMEENT SYSTEM SOFTWARE LICENSE AND EXTENDED WARRANTY, awarded by the Uniformed Services University of the Health Sciences (USUHS), a defense agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of the Lovelace Biomedical Research Institute. The contract has a firm fixed price of $502,324.27 and a completion date of December 22, 2020. The contract does not have a set-aside designation. LBERI is a...
This is a delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lovelace Biomedical and Environmental Research Institute, Inc. (doing business as Inhalation Toxicology Research Institute), a subsidiary of Lovelace Biomedical Research Institute. The $1,413,201.00 cost-plus-fixed-fee contract provides clinical research support services in support of audiological research at the Walter Reed National Military Medical Center. The...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for natural history studies in neuromuscular junction (NMJ) disease mouse models, with a period of performance from September 28, 2020 to December 31, 2021 and a total ceiling value of $2,366,151.00. The contract does not have a set-aside...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $625,343.90 contract is for the PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT under the Gene Therapy Resource Program (GTRP). Lovelace will provide a range of preclinical research services to support the...
This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
This is a $507,702.77 cost-plus-fixed-fee delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories focused on pharmacology and toxicology, preclinical vector development, and a clinical coordinating center. This contract...